020 7870 3936

Diagnostic Programme

Wearables Baseline
Review
at AEOM

All your data, properly integrated — wearables, bloodwork, lifestyle and history, synthesised into a clinical report you can actually use

Most patients now carry significantly more health data on their wrist than their GP has ever seen — months or years of Oura, Whoop, Apple Watch or Garmin readings, alongside bloodwork from various providers, possibly CGM data, possibly genomic results. The problem is that none of it is integrated. The Wearables Baseline Review is AEOM's structured solution: we combine your wearable data, your bloodwork, your medical and family history, your lifestyle context and your specific goals into a single comprehensive clinical report — clinician-reviewed, GP-signed, and used to inform everything we do with you next.

Key facts strip:

  • £395 — comprehensive Baseline Review with clinical report
  • All major wearable platforms supported (Oura, Whoop, Apple Watch, Garmin, Fitbit, Polar)
  • Includes structured questionnaire and clinical review consultation
  • Annual review included in Optimisation Membership
From

£1,400

Downtime

None

Session

30–75 min

Areas

Face · Neck · Body

Results

12–18 months

Introduction

Why this exists - the data integration problem

In the last five years, consumer health tracking has produced something genuinely new: most engaged wellness patients now carry significantly more health data on themselves than any clinician has ever had the opportunity to look at. An Oura ring captures four years of sleep and HRV data. A Whoop strap records 18 months of training and recovery patterns. An Apple Watch sits on top of basic activity tracking. Some patients add CGM data, some have done LifeCode GX or GlycanAge, some have multiple rounds of bloodwork from different providers, some have genomic data they paid for on a whim.

The problem isn't lack of data — it's that none of it talks to anything else. The wearable apps show their own metrics. The bloodwork lives as a PDF on your phone. The CGM sat in a separate platform. The genomic data is in another portal. No clinician you've ever seen has had time, infrastructure or incentive to integrate any of it into a coherent picture.

The Wearables Baseline Review addresses this directly. We pull your wearable data, your bloodwork, your lifestyle context, your medical and family history, and your specific goals into a structured clinical integration process — producing a comprehensive report that synthesises the lot into actionable findings. The report is drafted by a structured analytical process and signed off by our clinical lead and GP before delivery. You get the depth of multi-data-source integration with the safety of proper clinical review.

For most patients, this is the first time anyone has looked at the whole picture.

HOW IT WORKS

The process, end to end

The Baseline Review is structured across approximately three weeks, end to end:

Week 1 — Data Collection and Onboarding

Initial consultation (30 minutes): You attend AEOM (or join via video) for an onboarding consultation covering:

  • What the programme involves and what you can expect from the report
  • Authorisation for us to access your wearable data (read-only, via secure platform integrations)
  • Discussion of your specific goals and areas of interest
  • A structured medical and lifestyle questionnaire that you complete in your own time (typically 30–45 minutes online)
  • Identification of any existing bloodwork to incorporate, or arrangement of new bloodwork if appropriate

Data sources we integrate:

  • Wearable data: Oura, Whoop, Apple Watch, Garmin, Fitbit, Polar (and emerging platforms). We typically work with 3–12 months of historical data.
  • Bloodwork: AEOM panels, GP bloodwork (with your consent), other private bloodwork providers (Medichecks, Thriva, Forth, Numan)
  • Other diagnostics: CGM data, sleep assessment results, body composition data
  • Genetic/epigenetic data: GlycanAge, LifeCode GX, MyHeritage / 23andMe / Ancestry (where you wish to include)
  • Questionnaire data: Comprehensive medical history, family history, lifestyle factors, sleep, exercise, nutrition, stress, alcohol, supplements, current medications, specific concerns, goals and priorities

Week 2 — Synthesis and Drafting

Your data is integrated through our analytical framework — a structured process that identifies patterns, flags clinically significant findings, surfaces relationships between data sources (e.g. how your sleep affects your HRV, how your HRV affects your recovery, how your bloodwork findings interact with the lifestyle patterns in your wearable data), and drafts the initial report.

This is where the multi-data-source integration produces value. Individual data sources are informative in isolation; in combination, they reveal patterns and relationships that no single source shows. The drafting process uses structured analytical tools to handle the integration efficiently — but every output is then reviewed and signed off by our clinical team before it reaches you.

Week 3 — Clinical Review and Sign-Off

Your draft report is reviewed by:

  • Our Clinical Lead for clinical accuracy, appropriate framing of findings, and identification of anything requiring further investigation
  • Our Lead GP (Dr Ashik) for GP sign-off on the medical content, identification of findings appropriate for NHS referral, and any clinical concerns requiring escalation

Only after both reviews are complete is the report finalised and delivered to you.

Week 3 — Report Delivery and Review Consultation

You receive the comprehensive Baseline Review report (typically 15–25 pages depending on data complexity), plus a 60-minute review consultation walking through the findings together. The consultation is genuinely substantial — this is where the report becomes actionable, with specific recommendations, identified next steps, and a clear plan for what (if anything) to do based on what was found.

WHAT THE REPORT COVERS

Inside the Baseline Review report

The report structure is consistent across patients but the depth and emphasis varies based on what your data reveals. Typical contents:

Executive Summary

A clear overview of key findings, immediate priorities, and high-level recommendations. Designed to be readable in 5 minutes.

Health and Lifestyle Profile

Synthesised from your questionnaire — current health status, family history relevant to longevity and risk, lifestyle factors influencing your data patterns.

Cardiovascular and Metabolic Health

Integration of wearable cardiovascular data (resting heart rate, heart rate variability, recovery patterns) with bloodwork findings (lipids, glucose, HbA1c, inflammatory markers). Identification of cardiovascular risk factors and metabolic patterns relevant to your goals.

Sleep Quality and Architecture

Detailed analysis of your wearable sleep data over 3–12 months — sleep duration, efficiency, REM/Deep sleep distribution, awakening patterns, and chronological trends. If you've had a Clinical Sleep Assessment, this is integrated. Identification of sleep patterns affecting other domains (recovery, glucose, mood, cognitive function).

Recovery, HRV and Stress Patterns

HRV trends over time, recovery patterns relative to training and life stress, identification of chronic stress markers, and integration with lifestyle factors.

Activity, Exercise and Training Load

Patterns of activity, exercise intensity distribution, training load adequacy or excess for your goals, and identification of where exercise patterns are or aren't supporting your stated objectives.

Nutritional and Metabolic Indicators

Integration of bloodwork micronutrient findings, dietary patterns from questionnaire, and (where available) CGM data. Identification of nutritional priorities.

Hormonal Patterns (where applicable)

For patients with hormonal bloodwork — perimenopausal patterns in women, testosterone patterns in men — integrated with lifestyle and wearable findings.

Biological Age and Longevity Markers (where available)

HRV trends over time, recovery patterns relative to training and life stress, identification of chronic stress markers, and integration with lifestyle factors.

Risk Identification and Red Flags

Any findings requiring further investigation, GP referral, or specific intervention — clearly flagged with appropriate context.

Recommendations and Next Steps

Specific, prioritised recommendations — typically organised as:

  • Immediate priorities (0–4 weeks)
  • Short-term goals (1–3 months)
  • Long-term direction (3–12 months)

Recommendations link to AEOM programmes, consultations, treatments and external pathways where appropriate.

Appendix

Detailed data tables, charts, trend analyses and full data references — for patients who want to see the underlying detail.

WHO IT'S FOR

Who Wearables Baseline
Review is right for

The Wearables Baseline Review is well-suited if you are:

N

A long-term wearable user (6+ months of Oura, Whoop, Apple Watch or Garmin data) who has never had clinical interpretation of the data

N

An Optimisation Member at AEOM — the annual Baseline Review is included

N

Investing seriously in longevity and proactive health and want everything integrated into one picture

N

Multi-source data-rich — wearables plus bloodwork plus CGM plus possibly genomic data, with no integration so far

N

A high-performing executive, athlete or professional wanting comprehensive baseline before structured intervention

N

Confused by your wearable data — patterns that you don't understand, findings that contradict each other across platforms

N

Coordinating care across multiple providers (GP, private specialists, aesthetic clinics, nutritionist) and wanting a synthesised view to share

N

Post-significant life event (illness, major stress period, perimenopause, career transition) wanting structured stocktake

N

Considering health investment — programmes, sustained intervention, or major lifestyle change — and want the data foundation in place first

The Wearables Baseline Review may not be the right fit if you:

K

Don't currently use a wearable — the programme depends on having some wearable data to integrate. We'd recommend starting with a wearable for 2–3 months before the Review, or selecting a different starting point (Clinical Sleep Assessment, Bloodwork, Nutritionist Consultation)

K

Want medical diagnosis of conditions — this is a wellness integration tool, not a diagnostic service. For diagnosed clinical conditions, appropriate specialist pathways apply

K

Are seeking a single number or score — the report identifies patterns and recommendations across multiple domains rather than producing a "health score"

K

Expect immediate transformation from the report alone — the value is in the report informing the changes you make next; reports without follow-through change little

WHAT MAKES THIS DIFFERENT

How this differs
from existing services

Several services touch on parts of what the Baseline Review does. None integrate the full picture in the same way.

Vs Function Health (US)

Function Health offers comprehensive bloodwork with AI-assisted interpretation, currently US-only and focused on bloodwork-led longevity testing. It doesn't integrate wearable data, doesn't include questionnaire-based lifestyle synthesis, and doesn't include GP-level sign-off. The Baseline Review at AEOM extends meaningfully beyond bloodwork into multi-source integration with clinical sign-off.

Vs Zoe

Zoe combines CGM, microbiome testing and fat response analysis into a structured programme over multiple months — genuinely useful for patients committed to app-led metabolic optimisation. It doesn't integrate wearable data, bloodwork or comprehensive medical history; it's optimised for nutrition and metabolic patterns specifically. Different category of product.

Vs Inside Tracker

InsideTracker combines bloodwork and lifestyle questionnaires with algorithmic recommendations. It's a consumer product, US-led, without clinical sign-off or wearable integration. Useful as a self-serve tool; not the same as clinically integrated multi-source review.

Vs Premium Concierge Medicine

Premium concierge providers (Bupa, Echelon Health, the major hospital private wings) offer extensive screening and consultation but typically at significantly higher price points (£2,000–£10,000+) without the multi-source data integration that wearable users specifically benefit from. Our Baseline Review is a focused product addressing one specific need — multi-source integration — at an accessible price.

Vs Your GP

NHS GP care is appropriate for clinical management of diagnosed conditions and routine screening. GPs don't typically have time or infrastructure to integrate months of wearable data alongside private bloodwork and lifestyle context. Our Baseline Review is complementary to GP care, not a replacement — and findings appropriate for NHS pathway are flagged for referral.

The honest gap we're filling: comprehensive integration of patient-generated health data with clinical context and sign-off, at a price point that makes annual review accessible.

What the Baseline Review
will and won't do

It identifies patterns; it doesn't diagnose conditions. The report flags findings appropriate for further investigation but isn't a substitute for clinical diagnosis. Where findings suggest possible clinical issues, the report recommends appropriate next steps — typically GP investigation, specialist referral, or further AEOM-led testing.

The report is only as good as the data it draws from. Patients with minimal wearable data (less than 3 months), no bloodwork, and limited engagement with the questionnaire will get a less useful report than patients with rich, sustained data and full engagement. This isn't a magic product — it's a synthesis of what you bring to it.

It supports decisions; it doesn't make them. The report identifies priorities and provides recommendations. What you do with them is yours to decide. We can support implementation through AEOM programmes, consultations and treatments — but the agency is yours.

It's a snapshot, not a continuous service. A single Baseline Review reflects a moment in time. Annual review (included in Optimisation Membership) captures change over time and refines the picture as your patterns evolve.

AI-assisted doesn't mean AI-led. Our analytical process uses structured tools to handle the data integration efficiently — but every report is reviewed by our Clinical Lead and signed off by our GP before delivery. The clinical accountability sits with our clinical team, not with a piece of software. We're explicit about this because it matters: AI tools are useful for synthesis at scale; they're not safe to use without clinical oversight, and we don't.

It's a developing service. The Baseline Review programme is genuinely new — among the first of its kind in the UK. We're committed to continuous improvement as we refine the data integration, expand the supported data sources, and incorporate patient feedback. Early patients are getting a strong product that will continue to improve.

WHERE THIS IS GOING

The roadmap

The Baseline Review at launch supports the data sources most relevant to current wellness patients. Over 2026 and beyond, the programme will expand to integrate additional data:

    N

    Ambulatory blood pressure monitoring (ABPM) — for patients with hypertension, white coat syndrome, or cardiovascular risk

    N

    Holter monitor and longer cardiac rhythm data — for patients with arrhythmia history or cardiovascular concerns

    N

    DEXA body composition results — when integrated as a routine AEOM diagnostic

    N

    Ultrasound imaging findings — for patients with carotid intima-media or other vascular imaging

    N

    Expanded epigenetic panels — beyond GlycanAge and LifeCode GX as the category develops

    N

    Hormonal optimisation pathway data — as AEOM's hormonal optimisation services launch

    N

    Continuous metabolic data — long-term CGM and emerging continuous metabolic markers

    N

    Mental health and cognitive data — validated questionnaire-based assessments integrated alongside physical health data

    The vision is that AEOM members and engaged patients have a continuously refined health picture across every data source relevant to their goals — synthesised properly, reviewed clinically, and translated into action that compounds over years.

    PRICING

    Wearables Baseline Review pricing

    Programme

    Price

    Includes

    Wearables Baseline Review

    £395

    Initial consultation, wearable data integration, structured questionnaire, AI-assisted analysis, clinical review and GP sign-off, comprehensive report (15–25 pages), 60-minute review consultation

    Baseline Review + Comprehensive Wellness Panel

    £575

    Above plus Well Person Profile bloodwork integrated into report

    Baseline Review + GlycanAge

    £695

    Above plus GlycanAge biological age testing integrated

    Annual Refresh Review (within 12 months)

    £275

    Year-over-year comparison and updated recommendations

    Klarna instalments available on bundled programmes, subject to approval.

    As part of a Programme: Wearables Baseline Review is included in:

    • Regenerative Performance Programme (£2,495) — comprehensive Review integrated with the programme's diagnostics

    Membership: Optimisation Membership (£250/month or £2,500/year) — annual Wearables Baseline Review included as a core member benefit.

    COMBINE WITH

    Treatments that combine well
    with the Baseline Review

    The Baseline Review's value compounds significantly when paired with the right data sources and follow-through interventions.

    Baseline Review + Comprehensive Wellness Panel

    The most-recommended combination. Bloodwork plus wearable data plus medical history produces a meaningfully complete picture; bloodwork alone or wearable alone produces partial pictures. Standard pairing for first-time Baseline Review patients.

    Baseline Review + Continuous Glucose Monitoring

    CGM data integrated into the Baseline Review reveals patterns invisible to wearables alone — particularly around food, meal timing, and the relationship between glucose and sleep/HRV. Particularly valuable for metabolic or weight-focused patients.

    Baseline Review + Clinical Sleep Assessment

    WatchPAT findings integrated alongside wearable sleep data produces clinical-grade sleep insight. Many patients discover that their Oura "sleep score" has been masking actual sleep apnea — the Baseline Review with sleep assessment integrated catches this.

    Baseline Review + GlycanAge / LifeCode GX

    Biological age and epigenetic data integrated into the wider context shows how your lifestyle patterns are influencing your long-term ageing trajectory — not just where you are today, but where you're heading.

    Baseline Review + Nutritionist Consultation

    The Baseline Review identifies patterns; the nutritionist consultation translates findings into practical dietary change. Often the most behaviour-changing pairing.

    Baseline Review + Optimisation Membership

    The programme this is built for. Annual Baseline Review plus monthly membership inclusions plus integrated programme treatments produces sustained, data-informed care over years rather than one-off intervention.

    Frequently asked questions

    Which wearables do you support?

    At launch, we support Oura (Generation 2 onwards), Whoop (all versions), Apple Watch (Series 4 onwards), Garmin (most current platforms), Fitbit (recent platforms) and Polar (Vantage and Ignite series). We're actively adding platform support as the wearable market evolves; ask at consultation if you use a different platform.

    How much wearable data do you need?

    Ideally 3–12 months of data for meaningful trend analysis. Patients with less data (1–3 months) can still benefit but the longitudinal patterns are less complete. Patients with 12+ months get the richest review. If you've just started using a wearable, we'd typically suggest waiting 2–3 months before booking — or starting with a different AEOM entry point (Bloodwork, Clinical Sleep Assessment, Nutritionist Consultation).

    How does the AI part actually work?

    We use structured analytical tools to handle data integration across multiple sources at a scale that manual review couldn't address efficiently. The tools identify patterns, surface relationships between data sources, flag clinically significant findings, and draft the initial report content. Every draft is then reviewed and signed off by our Clinical Lead and our Lead GP (Dr Ashik) before delivery. The clinical accountability sits with the clinical team, not the software. We're explicit about this because it matters — AI is useful for synthesis at scale, but it's not safe to use clinically without proper oversight.

    Is my data secure?

    Yes. We're ICO-registered (ZC073276), operate under strict GDPR Article 9 protocols for special category health data, and use secure infrastructure for data storage and processing. Your data is used solely for your Baseline Review and ongoing AEOM care, with your explicit consent. We don't sell data, share it with third parties for marketing, or use it for purposes beyond your care without specific further consent. Full data protection details are available at consultation.

    Can I see the AI's draft, or just the final report?

    You receive the final clinician-signed report. We don't share AI draft outputs because (a) drafts may contain errors that the clinical review catches and corrects, (b) draft outputs without clinical context can be misleading, and (c) the clinical sign-off is what makes the report safe to act on. We're transparent about the process; we're not transparent about specific intermediate outputs because that would compromise the clinical safety model.

    Will the report tell me how long I'll live or my "real age"?

    No. The report identifies patterns and recommendations relevant to your health and goals — not predictions about longevity. If you've had GlycanAge or LifeCode GX testing, those findings are integrated and contextualised in the report. Generic longevity predictions are not part of the deliverable; we don't believe they're scientifically supported in the way they're often marketed.

    What if the report identifies something concerning?

    Findings appropriate for further investigation are clearly flagged in the report with recommended next steps — typically GP investigation, specialist referral, or further testing.

    Our Lead GP signs off the report specifically with this responsibility in mind. If something serious is identified, we'd contact you promptly to discuss next steps and would not wait for the scheduled review consultation.

    Can I share the report with my GP?

    Yes — with your consent, we can share the report directly with your GP. Many patients find this useful as a structured presentation of multi-source data that their GP wouldn't typically have time to integrate themselves.

    How is this different from just reading my Oura app?

    The Oura app shows you Oura data well. The Baseline Review integrates Oura data alongside your bloodwork, your medical history, your family history, your goals, your lifestyle context, and (where available) CGM, biological age testing, and other data sources — synthesised with clinical interpretation. The difference is the integration and the clinical context, not the wearable data itself.

    What's the difference between the £395 standalone and the included Membership version?

    Same product. The £395 is the standalone price for non-members; Optimisation Members receive the Baseline Review as part of their annual membership inclusions. For patients who plan to repeat the Review annually, membership is significantly better value.

    How often should I have the Baseline Review repeated?

    Annual repetition is what we recommend — and what's included in Optimisation Membership. The year-over-year comparison is where compounded value emerges; you see how your patterns have changed, what's improved, what hasn't, and how recommendations should evolve. Patients with significant life changes (major illness, perimenopause onset, post-pregnancy, major lifestyle shifts) may benefit from earlier repeat.

    Can my partner and I do this together?

    Yes — partner bookings are easily arranged. We don't currently offer specific couple discounts, but the practical experience is improved when partners review together (particularly for sleep and lifestyle patterns where partner context matters). Speak to us at booking.

    Where is AEOM located?

    Our clinic is at 116 Seymour Place in Marylebone, London.

    Marylebone, Baker Street and Edgware Road stations are all under ten minutes on foot. Free street parking is available after 6.30pm, with paid bays on York Street nearby — daytime parking is reimbursed for treatments over £200. Treatments are by appointment only.

    Ready to book a
    Wearables Baseline Review?

    For wearable users sitting on months or years of data they've never had clinically integrated, this is one of the highest-leverage diagnostic programmes AEOM offers. Book a Baseline Review, or speak to our team about how it fits into Optimisation Membership and broader wellness pathways.